Science & technology | The antibiotics crisis

Western firms are becoming interested in a Soviet medicine

“Phage therapy” aims to use viruses to cure bacterial infections

^BT4 bacteriophage.^b Coloured transmission electron micrograph (TEM) of a ^IT4 bacteriophage^i virus. The swollen structure at top is the head, which contains DNA inside a protein coat. Attached to this is the tail, consisting of a tube-like sheath and tail fibres (at bottom). ^IT4 bacteriophages^i are parasites of ^IEscherichia coli^i, a bacteria common in the human gut. The virus attaches itself to the host bacteria cell wall by its tail fibres; the sheath then contracts, injecting the contents of the head (DNA) into the host. The viral DNA makes the bacteria manufacture more copies of the virus. Magnification: x110,000 at 6x4.5cm size.
Image: Science Photo Library
|Tbilisi

It was on the golf course that Barry Rud first noticed something was seriously wrong. A trim 60-year-old who played hockey as a young man, he found himself unable to take more than a few steps without gasping for breath. His doctors said he had caught a strain of Pseudomonas aeruginosa, one of the growing number of “superbugs” that have evolved resistance to many common antibiotics.

This article appeared in the Science & technology section of the print edition under the headline “Viral therapy”

From the May 6th 2023 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Science & technology

A person sleeping. The frame is split between night and day.

Does melatonin work for jet lag?

It can help. But it depends where you’re going

A network of pixelated hearts

Training AI models might not need enormous data centres

Eventually, models could be trained without any dedicated hardware at all


Workers harnessed unto the facade of the Museum of the Future, United Arab Emirates.

How the Gulf’s rulers want to harness the power of science

A stronger R&D base, they hope, will transform their countries’ economies. Will their plan work?


Cancer vaccines are showing promise at last

Trials are under way against skin, brain and lung tumours

New firefighting tech is being trialled in Sardinia’s ancient forests

It could sniff out blazes long before they spread out of control

Can Jeff Bezos match Elon Musk in space?

After 25 years, Blue Origin finally heads to orbit, and hopes to become a contender in the private space race